Digital Therapeutics Leader GAIA positions itself as a global pioneer in clinically validated digital therapeutics with FDA-cleared products, presenting a compelling value proposition to payers and physicians seeking non-drug treatment options.

Clinical Rigor & Trials Emphasize GAIA's multidisciplinary team and expertise in Phase II & III trials, regulatory affairs, and market access to reassure potential customers of robust evidence generation and regulatory readiness for major markets.

Healthcare Partnerships Target payers, health systems, and clinics that prioritize digital health solutions with validated outcomes, leveraging GAIA’s FDA-cleared products and clinical validation to drive adoption and reimbursement discussions.

Global Market Access Leverage GAIA’s readiness for major markets and its regulatory/commercial capabilities to propose scalable deployment across regions, supported by a cross-functional team capable of navigating different healthcare ecosystems.

Technology & AI Leverage Highlight GAIA’s tech stack and collaboration tools (AWS, GitHub, AI capabilities) to propose modern deployment, data security, and ongoing product iteration that can meet enterprise needs for healthcare organizations.